GaBI Journal is an independent and peer reviewed academic journal. GaBI Journal encompasses all aspects of generic and biosimilar medicines development and use, from fundamental research up to clinical application and policies.

GaBI Journal is currently producing the following educational editorial series: 1) Biosimilars for healthcare professionals; 2) Biosimilarity and Interchangeability; 3) Generic immunosuppressants. Contact us for more information.

Those who wish to discuss future topics, feel free to contact GaBI Journal's Editor-in-chief: Professor Philip Walson, MD, here.